Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing

29th April 2021 Uncategorised 0

Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing
sharon.coey
Thu, 04/29/2021 – 07:13

More: Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing
Source: fierce